Literature DB >> 10027399

Expression of neurotrophins and their receptors in human bone marrow.

E Labouyrie1, P Dubus, A Groppi, F X Mahon, J Ferrer, M Parrens, J Reiffers, A de Mascarel, J P Merlio.   

Abstract

The expression of neurotrophins and their receptors, the low-affinity nerve growth factor receptor (p75LNGFR) and the Trk receptors (TrkA, TrkB, and TrkC), was investigated in human bone marrow from 16 weeks fetal age to adulthood. Using reverse transcription-polymerase chain reaction, all transcripts encoding for catalytic and truncated human TrkB or TrkC receptors were detected together with trkAI transcripts, whereas trkAII transcripts were found only in control nerve tissues. Transcripts for the homologue of the rat truncated TrkC(ic113) receptor were identified for the first time in human tissue. Stromal adventitial reticular cells were found immunoreactive for all neutrophin receptors. In contrast, hematopoietic cell types were not immunoreactive for p75LNGFR but showed immunoreactivity for one or several Trk receptors. TrkA immunoreactivity was found in immature erythroblasts. Catalytic TrkB immunoreactivity was observed in eosinophilic metamyelocytes and polymorphonuclear cells. Truncated TrkB immunoreactivity was found in erythroblasts and megacaryocytes. Immunoreactivity for both catalytic and truncated TrkC receptor was observed in promyelocytes, myelocytes, some polymorphonuclear cells and megacaryocytes. Neutrophin transcript levels appeared higher at fetal than at adult stages, no variation in Trk family transcript levels was observed. The local expression of neurotrophin genes suggests a wide range of paracrine and/or autocrine mode of action through their corresponding receptors within the bone marrow.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10027399      PMCID: PMC1849993          DOI: 10.1016/S0002-9440(10)65287-X

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  60 in total

1.  Mast cells synthesize, store, and release nerve growth factor.

Authors:  A Leon; A Buriani; R Dal Toso; M Fabris; S Romanello; L Aloe; R Levi-Montalcini
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

2.  An alternatively spliced form of the nerve growth factor receptor TrkA confers an enhanced response to neurotrophin 3.

Authors:  D O Clary; L F Reichardt
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

3.  Emotional stress induced by parachute jumping enhances blood nerve growth factor levels and the distribution of nerve growth factor receptors in lymphocytes.

Authors:  L Aloe; L Bracci-Laudiero; E Alleva; A Lambiase; A Micera; P Tirassa
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

4.  Expression and functionality of the trkA proto-oncogene product/NGF receptor in undifferentiated hematopoietic cells.

Authors:  S Chevalier; V Praloran; C Smith; D MacGrogan; N Y Ip; G D Yancopoulos; P Brachet; A Pouplard; H Gascan
Journal:  Blood       Date:  1994-03-15       Impact factor: 22.113

5.  Nerve growth factor prevents apoptosis of rat peritoneal mast cells through the trk proto-oncogene receptor.

Authors:  K Kawamoto; T Okada; Y Kannan; H Ushio; M Matsumoto; H Matsuda
Journal:  Blood       Date:  1995-12-15       Impact factor: 22.113

6.  TrkA cross-linking mimics neuronal responses to nerve growth factor.

Authors:  D O Clary; G Weskamp; L R Austin; L F Reichardt
Journal:  Mol Biol Cell       Date:  1994-05       Impact factor: 4.138

7.  Activation of the sphingomyelin cycle through the low-affinity neurotrophin receptor.

Authors:  R T Dobrowsky; M H Werner; A M Castellino; M V Chao; Y A Hannun
Journal:  Science       Date:  1994-09-09       Impact factor: 47.728

Review 8.  Neurotrophic factors: from molecule to man.

Authors:  R M Lindsay; S J Wiegand; C A Altar; P S DiStefano
Journal:  Trends Neurosci       Date:  1994-05       Impact factor: 13.837

9.  Poor response of cultured mast cells derived from mi/mi mutant mice to nerve growth factor.

Authors:  T Jippo; H Ushio; S Hirota; H Mizuno; A Yamatodani; S Nomura; H Matsuda; Y Kitamura
Journal:  Blood       Date:  1994-11-01       Impact factor: 22.113

10.  Different neurotrophins are expressed and act in a developmental sequence to promote the survival of embryonic sensory neurons.

Authors:  V L Buchman; A M Davies
Journal:  Development       Date:  1993-07       Impact factor: 6.868

View more
  45 in total

1.  p75(NTR) mediates neurotrophin-induced apoptosis of vascular smooth muscle cells.

Authors:  S Wang; P Bray; T McCaffrey; K March; B L Hempstead; R Kraemer
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

Review 2.  Neurotrophins and the immune system.

Authors:  José A Vega; Olivia García-Suárez; Jonas Hannestad; Marta Pérez-Pérez; Antonino Germanà
Journal:  J Anat       Date:  2003-07       Impact factor: 2.610

Review 3.  Cardiovascular actions of neurotrophins.

Authors:  Andrea Caporali; Costanza Emanueli
Journal:  Physiol Rev       Date:  2009-01       Impact factor: 37.312

4.  Involvement of neurotrophins and their receptors in spondyloarthritis synovitis: relation to inflammation and response to treatment.

Authors:  M Rihl; E Kruithof; C Barthel; F De Keyser; E M Veys; H Zeidler; D T Y Yu; J G Kuipers; D Baeten
Journal:  Ann Rheum Dis       Date:  2005-04-07       Impact factor: 19.103

5.  Mesenchymal stem cells promote proliferation of endogenous neural stem cells and survival of newborn cells in a rat stroke model.

Authors:  Seung-Wan Yoo; Sung-Soo Kim; Soo-Yeol Lee; Hey-Sun Lee; Hyun-Soo Kim; Young-Don Lee; Haeyoung Suh-Kim
Journal:  Exp Mol Med       Date:  2008-08-31       Impact factor: 8.718

Review 6.  Stem cell-based therapies for spinal cord injury.

Authors:  Rishi S Nandoe Tewarie; Andres Hurtado; Ronald H Bartels; Andre Grotenhuis; Martin Oudega
Journal:  J Spinal Cord Med       Date:  2009       Impact factor: 1.985

7.  The TP53 Apoptotic Network Is a Primary Mediator of Resistance to BCL2 Inhibition in AML Cells.

Authors:  Tamilla Nechiporuk; Stephen E Kurtz; Olga Nikolova; Tingting Liu; Courtney L Jones; Angelo D'Alessandro; Rachel Culp-Hill; Amanda d'Almeida; Sunil K Joshi; Mara Rosenberg; Cristina E Tognon; Alexey V Danilov; Brian J Druker; Bill H Chang; Shannon K McWeeney; Jeffrey W Tyner
Journal:  Cancer Discov       Date:  2019-05-02       Impact factor: 39.397

Review 8.  Neuronal Activity in Ontogeny and Oncology.

Authors:  Humsa Venkatesh; Michelle Monje
Journal:  Trends Cancer       Date:  2017-02-13

9.  Harvest site influences the growth properties of adipose derived stem cells.

Authors:  Patricia E Engels; Mathias Tremp; Paul J Kingham; Pietro G di Summa; René D Largo; Dirk J Schaefer; Daniel F Kalbermatten
Journal:  Cytotechnology       Date:  2012-10-25       Impact factor: 2.058

10.  High-affinity neurotrophin receptors and ligands promote leukemogenesis.

Authors:  Zhixiong Li; Gernot Beutel; Mathias Rhein; Johann Meyer; Christian Koenecke; Thomas Neumann; Min Yang; Jürgen Krauter; Nils von Neuhoff; Michael Heuser; Helmut Diedrich; Gudrun Göhring; Ludwig Wilkens; Brigitte Schlegelberger; Arnold Ganser; Christopher Baum
Journal:  Blood       Date:  2008-12-04       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.